Mike Stencel

Urologic oncologist @CAMCUrologyiam. Health equity, teaching, outcomes. Proud father and husband. Outdoor and sports enthusiast.

[Mike Stencel @UroStence]

Important work, thank you to those behind the scenes working on behalf of our patients!

[Amer. Urol. Assn. @AmerUrological]

A major milestone in public health just arrived. The introduction of H.R. 7602, the State of Men’s Health Act, marks a bold federal commitment to improving men’s health outcomes and tackling disparities that have persisted for decades. The AUA is honored to have played a key role in shaping this legislation and supporting the creation of a new Office of Men’s Health, which will coordinate nationwide efforts to improve awareness, prevention, and care.

A big shoutout to Congressman @RepTroyCarter and @RepGregMurphy for introducing and supporting this monumental bill. This is a turning point, and we’re proud to be part of it. #AUAAdvocacy

🔗 Click to learn more about the bill: https://t.co/EPqoOSj8Om

[Mike Stencel @UroStence]

@OHSUurology @BrielleGolds @kpoulos_ @CNU_Med @WayneUrology @UNCurology Way to go Divya!

[Mike Stencel @UroStence]

Congrats and welcome to the team!! 👏

[CAMC Urology Residency @CAMCUrologyIAM]

Congratulations to Dominic Collins and Johnathan Yoder on matching into the Vandalia Health CAMC Urology Residency! We are excited to welcome them to our program.

[Sia Daneshmand, M.D. @siadaneshmand]

Should #radicalcystectomy ever be considered for consolidate therapy post EV/P?https://t.co/kM8tuDdXih @PGrivasMDPhD @shilpaonc @tompowles1 @MattGalsky @OncBrothers @montypal @DrYukselUrun @nirajaiims @UroDocAsh @IBCG_BladderCA @SWOG @UroOnc @BladderCancerUS

[Matt Cooperberg @dr_coops]

Great paper @EUplatinum confirming safety of #activesurveillance for #prostatecancer out to 25 years in the Göteborg-1 trial.

https://t.co/1Rd4Q73ewS

[Michael Hofman @DrMHofman]

620 of 660 patients randomised in #PRIMARY2
🎯Bringing PSMA PET from staging to DIAGNOSIS
🏁The finishing line approaches

Thank-you⭐investigators @ButeauJames @drlouiseemmett @DrDanielMoon @declangmurphy + many more

Supported by @PeterMacCC @SVHSydney @PCF_Science @pros_tic @ANZUPtrials

Results 2026

[Tom Powles @tompowles1]

With the final analysis of the last of the 1st line metastatic clear cell RCC trials combination trials it’s still fair to say ‘pick one and use it well’. #GUARDSymposium2025 Ipi/nivo is less good at getting initial control but has less long term toxicity. @brian_rini @OncoAlert

[Mike Stencel @UroStence]

@UPMCUrology @JohnMyrga @shyam_patnaik1 @PintauroMD @ChrisStaniorski 👏 congrats guys!!!!

[Zach Klaassen @zklaassen_md]

🔥New feature on @urotoday 🔥

When you click on the Journal Club link 👇, you can watch/listen to the discussion AND click "Download Journal Club Slides" to add to your slide deck library

Great for:
- Trainees
- Putting together Grand Rounds talks
- Residency/Fellowship journal clubs
- Etc

[Mike Stencel @UroStence]

Incredible uros and even better people. Honored to have taken part in their training. Congratulations!!

[CAMC Urology Residency @CAMCUrologyIAM]

We're incredibly proud to congratulate our two graduating Urology residents, Thomas Cato, DO, and Carly Ulrich, DO! Their commitment to excellence and professional growth throughout the program has been exceptional. We can't wait to see all they’ll accomplish next!

[CAMC Urology Residency @CAMCUrologyIAM]

We're incredibly proud to congratulate our two graduating Urology residents, Thomas Cato, DO, and Carly Ulrich, DO! Their commitment to excellence and professional growth throughout the program has been exceptional. We can't wait to see all they’ll accomplish next!

[Mike Stencel @UroStence]

@daviesbj Congrats Katie!!

[Tom Powles @tompowles1]

At #ASCO25 : New Nectin4/PD1 combo data with response rates similar to EVP in bladder cancer. Also DV/toripalimab is better than chemo (press release). There multiple ways of beating 1st line chemo in UC. As chemo becomes less relevant a key question is around ADC sequencing

[Andrew M. Ibrahim MD, MSc @AndrewMIbrahim]

Hospitals Acquired By Private Equity Firms: Increased Postoperative Mortality For Common Inpatient Surgeries
@DiazAdrian10 @jdimick1 @Health_Affairs @UMichCHOP
https://t.co/w7J65hk7N3

[Amer. Urol. Assn. @AmerUrological]

Calling all urology professionals! ☎️

We're excited to announce the launch of our Data Research Program (DRP), open to all AUA members. This is your opportunity to drive impactful research using real-world data. 📈

✍️ Submit your Letter of Intent by June 22nd to be considered!

Learn more here! ➡️ https://t.co/lc2otSDEAe

[Mike Stencel @UroStence]

Congrats to Jared Zopp, @CAMCUrologyIAM resident all-star 🌟 for his amazing presentation at #AUA25

[Benjamin J. Davies MD, MBA @daviesbj]

Star resident @SkupinPeyton representing our private equity data describing how PE avoids lower socioeconomic areas #AUA25

[Laura Bukavina @LauraBukavinaMD]

BOND-003 Cohort C Update at #AUA25 ➡️
Intravesical Cretostimogene Grenadenorepvec for HR BCG-unresponsive NMIBC
•75.5% overall CR rate
•64.1% CR at 12 months, 58.3% CR at 24 months📉
•97.3% free from MIBC progression at 24 mo

[Mike Stencel @UroStence]

@UPMCUrology 😍

[Vignesh Packiam, MD @VigneshPackiam]

Just in time for AUA - A high-quality succinct review on contemporary intravesical therapy on NMIBC by the great @saumyg & all ��️ colleagues in @EUplatinum

Beautiful figures too!

A valuable resource for patients & urologists @BladderCancerUS @SUO_YUO

https://t.co/nLhAa3JBq2